Preferred Label : Clinical Trial Notification of Safety or Other Trial Information Documentation;

NCIt related terms : Notification to Regulatory Authority of Safety/Trial Information; Notification of Safety Information; Safety Report; Notf Safe Info; Notification of Safety or Trial Information;

Alternative definition : CareLex: Notification to Regulatory Authorities of any trial events that could adversely affect the safety of subjects, impact the conduct of the trial or alter the regulatory authority's approval/favorable opinion to continue the trial. Notifications may include but are not limited to Quarterly line listings, suspected unexpected serious adverse reactions (SUSARs), Council for International Organizations of Medical Sciences (CIOMS), MedWatch, Analysis of Similar Events, Serious Breaches, cover letters and/or country-specific reporting forms. [TMF-RM]; CDISC: Documentation submitted to the regulatory authorities pertaining to any events that may impact the safety of subjects or the conduct of the clinical trial.;

Details


Main resources

You can consult :


https://assurance-maladie.ameli.fr/etudes-et-donnees/2024-vedolizumab-ustekinumab-anti-tnf-grossesse-mici
2024
France
scientific and technical information
safety
TNF Gene
Ustekinumab
inflammatory bowel disease, nos
tumor necrosis factor
Institutional Review Board Independent Ethics Committee Notification of Safety Information Documentation
Physically Feel in Bad Condition
tumor necrosis factors
Safety Report
Clinical Trial Notification of Safety or Other Trial Information Documentation
chronic disease, nos
Vedolizumab
research report
vedolizumab
disease
Tumor Necrosis Factor
anti-TNF
Ustekinumab
Chronic Disease
Pregnant People
inflammatory bowel diseases
vedolizumab
pregnancy, nos
albumin/globulin ratio
chronic disease
Gravida

---
https://www.vie-publique.fr/rapport/294422-rapport-sur-lapplication-des-lois-de-financement-de-la-securite-sociale
2024
France
technical report
law enforcement
Social Security Retirement Benefit
Safety Issue Application
Safety Report
financial support
Funding
Institutional Review Board Independent Ethics Committee Notification of Safety Information Documentation
research report
social security
albumin/globulin ratio
Clinical Trial Notification of Safety or Other Trial Information Documentation

---
https://iris.who.int/bitstream/handle/10665/376333/WHO-WHE-EPP-2024.3-fre.pdf
2024
Switzerland
public health guidelines
Montreal Cognitive Assessment Orientation Test
Biological Son
Biological or Textual Reference to Actual Test or Parameter
CDISC ADAS-Cog - Orientation Summary Score
orientation
biology
Clinical Trial Notification of Safety or Other Trial Information Documentation
Referral
Biological
Biological Challenge Agent
SARS Coronavirus
laboratory reporting, nos
Biology
biology
Institutional Review Board Independent Ethics Committee Notification of Safety Information Documentation
SARS-CoV-2
safety
containment of biohazards
Direction
Orientation
Referring
Safety Report
laboratories
COVID-19 Infection
Biological Agent
orientation, nos
research report
COVID-19

---
Nous contacter.
08/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.